Literature DB >> 10952665

Cytochrome P450 inactivation by serum from humans with a viral infection and serum from rabbits with a turpentine-induced inflammation: the role of cytokines.

A M Bleau1, M C Levitchi, H Maurice, P du Souich.   

Abstract

Serum from humans with an acute upper respiratory viral infection and from rabbits with turpentine-induced inflammation reduce the catalytic activity of hepatic cytochrome P450 (P450). The aim of this study was to identify the serum mediators responsible for the decrease in P450 activity. Rabbit and human sera were fractionated by size exclusion chromatography and the fractions tested for their ability to reduce the activity and amount of P450 after 4 h of incubation with hepatocytes from turpentine-treated rabbits (H(INF)). Rabbit and human sera decreased P450 activity by around 40% without any change in the amount of CYP1A1 and 1A2 apoproteins. In rabbit serum, the fraction containing proteins of M(r) 23-15 kDa decreased P450 content by 41%, but did not alter the amount of the apoproteins. Anti-IL-6 antibody added to the M(r) 23-15 kDa fraction restored P450 content to 97% of control values, while anti-IL-1beta, TNF-alpha and IFN-gamma antibodies had no effect. Supporting the role of IL-6, incubation of H(INF) in the presence of IL-6 for 4 h reduced P450 content by 40%. In human serum, the fraction containing proteins of M(r) >95 kDa lowered P450 content by 43% without modifying the amounts of CYP1A1/2. Neutralization experiments showed that IFN-gamma, IL-6, and IL-1beta contributed to the decrease in P450 content. In conclusion, the present results demonstrate that IL-6, and IFN-gamma, IL-6 and IL-1beta are the serum mediators released in vivo by a turpentine-induced inflammatory reaction in the rabbit and an upper respiratory viral infection in humans, respectively, inactivating hepatic P450.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952665      PMCID: PMC1572253          DOI: 10.1038/sj.bjp.0703486

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

Review 2.  SDS polyacrylamide gel electrophoresis of proteins.

Authors:  B J Smith
Journal:  Methods Mol Biol       Date:  1994

Review 3.  Detection of polypeptides on immunoblots using secondary antibodies or protein A.

Authors:  N J Kruger
Journal:  Methods Mol Biol       Date:  1994

Review 4.  The interleukin-1 family: 10 years of discovery.

Authors:  C A Dinarello
Journal:  FASEB J       Date:  1994-12       Impact factor: 5.191

5.  Theophylline N-demethylations as probes for P4501A1 and P4501A2.

Authors:  M A Sarkar; B J Jackson
Journal:  Drug Metab Dispos       Date:  1994 Nov-Dec       Impact factor: 3.922

6.  Classification of alpha 2-macroglobulin-cytokine interactions based on affinity of noncovalent association in solution under apparent equilibrium conditions.

Authors:  K P Crookston; D J Webb; B B Wolf; S L Gonias
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

7.  Differential effect of cytokines on the phenobarbital or 3-methylcholanthrene induction of P450 mediated monooxygenase activity in cultured rat hepatocytes.

Authors:  M A Clark; B A Bing; P E Gottschall; J F Williams
Journal:  Biochem Pharmacol       Date:  1995-01-06       Impact factor: 5.858

8.  Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6.

Authors:  J Q Chen; A Ström; J A Gustafsson; E T Morgan
Journal:  Mol Pharmacol       Date:  1995-05       Impact factor: 4.436

9.  Anti-tumor necrosis factor-alpha prevents decreased ventricular contractility in endotoxemic pigs.

Authors:  M J Herbertson; H A Werner; C M Goddard; J A Russell; A Wheeler; R Coxon; K R Walley
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

10.  Canine acute phase response: relationship between serum cytokine activity and acute phase protein in dogs.

Authors:  K Yamashita; T Fujinaga; T Miyamoto; M Hagio; Y Izumisawa; T Kotani
Journal:  J Vet Med Sci       Date:  1994-06       Impact factor: 1.267

View more
  6 in total

1.  Hypoxia-induced down-regulation of CYP1A1/1A2 and up-regulation of CYP3A6 involves serum mediators.

Authors:  Caroline Fradette; Anne-Marie Bleau; Vincent Pichette; Nathalie Chauret; Patrick Du Souich
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

2.  Selective downregulation of hepatic cytochrome P450 expression and activity in a rat model of inflammatory pain.

Authors:  Denis Projean; Sophie Dautrey; Huy Khan Vu; Thierry Groblewski; Jean-Louis Brazier; Julie Ducharme
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

3.  Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450.

Authors:  Josée Michaud; Pierre Dubé; Judith Naud; Francois A Leblond; Karine Desbiens; Alain Bonnardeaux; Vincent Pichette
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

4.  Roles of nitric oxide in inflammatory downregulation of human cytochromes P450.

Authors:  Alison E Aitken; Choon-Myung Lee; Edward T Morgan
Journal:  Free Radic Biol Med       Date:  2007-12-23       Impact factor: 7.376

Review 5.  Disease-drug and drug-drug interaction in COVID-19: Risk and assessment.

Authors:  Devendra Kumar; Neerja Trivedi
Journal:  Biomed Pharmacother       Date:  2021-04-27       Impact factor: 7.419

6.  Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms.

Authors:  Mahmoud A El-Ghiaty; Sherif M Shoieb; Ayman O S El-Kadi
Journal:  Med Hypotheses       Date:  2020-06-26       Impact factor: 1.538

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.